The variceUa-zoster virus (VZV) glycoprotein B (gB) is a major viral antigen which elicits immunity and neutralizing antibodies. In this study, the genomic map position and DNA sequence of a simian varicella virus (SVV) homologue of the VZV gB gene was identified and the transcript analysed. A 32P-labelled VZV gB DNA probe hybridized to a subclone of the SVV BamHI B restriction endonuclease fragment indicating the fine map position of SVV DNA sequences homologous to the VZV gB gene. The SVV gB DNA sequence was determined and analysis revealed a 2751 base pair open reading frame (ORF) with 71.1% identity to the VZV gB gene and 53-8 % identity to the herpes simplex type 1 gB gene. The SVV gB ORF encodes a 916 amino acid polypeptide with a predicted molecular mass of 104K. The deduced SVV and VZV gB polypeptides share 78.9 % amino acid identity and predicted N-linked glycosylation sites, cleavage sites and transmembrane regions. 3~P-labelled SVV gB DNA and RNA probes hybridized to a 3"5 kilobase SVV polyadenylated transcript. Primer extension experiments identified transcript start sites for the SVV and VZV gB genes and permitted a comparison of the sequences upstream of the SVV and VZV gB ORFs. The SW and VZV gB promoter elements are similar in content and align closely. The VZV gB transcript start site suggests a gB polypeptide initiation site which is inconsistent with the previously reported ATG start codon.
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Simian varicella virus (SVV) infection of non-human
primates is a useful model for the study and evaluation of varicella-zoster virus (VZV) pathogenesis, chemotherapy and vaccines (Oakes & d'Offay, 1988; Soike, 1992) . SVV is an alphaherpesvirus responsible for numerous varicella-like epizootics of non-human primates (Ayres, 1971; Riopelle et al., 1971; McCarthy et al., 1968; Takasaka et al., 1990) . Moderate SVV infections of monkeys are characterized by fever and vesicular skin rash and clinically resemble VZV infection of immunocompetent children (Blakely et al., 1973) . In contrast, severe SVV infections of non-human primates are characterized by disseminated disease similar to VZV infection of immunocompromised patients (Clarkson et al., 1967) .
Besides clinical similarities between human and simian varicella, SVV and VZV are genetically and antigenically related. The SVV and VZV genomes are similar in size and structure, share 70 to 75 % DNA identity, and are collinear regarding gene organization Clarke et al., 1992; Gray & Oakes, 1984; . Serum from SVV infected monkeys crossThe GenBank accession number for the sequence reported in this paper is U12388.
reacts with VZV antigens as measured by complement fixation, viral neutralization and immunoprecipitation assays (Felsenfeld & Schmidt, 1977; . In addition, immunization with VZV protects non-human primates from simian varicella following subsequent challenge with SVV (Felsenfeld & Schmidt, 1979) . SVV immune serum immunoprecipitates an extensive number of VZV proteins including several glycoproteins . The VZV DNA sequence predicts 71 open reading frames (ORFs) including six potential glycoprotein genes (gE, gB, gH, gI, gC and gL; Davison & Scott, 1986) . Southern hybridization demonstrates SVV DNA sequences homologous to the VZV gE, gB, gH and gI genes . In addition, analysis of the SVV gE and gI predicted polypeptide sequences indicates significant amino acid identity to the homologous VZV polypeptides . These studies indicate that SVV and VZV have homologous glycoproteins and predicts that the SVV and VZV glycoproteins share comparable functions.
In this study, a SVV homologue of the VZV gB (formerly gpII) gene was identified. The genomic map position and the DNA sequence of the SVV gB gene were determined. The predicted SVV gB polypeptide sequence was analysed and compared to the VZV gB and other herpesvirus gB homologues. In addition, the SVV gB gene transcript was characterized and the promoter regions of the SVV and VZV gB genes were compared. A previous study indicated that VZV gB DNA sequences hybridize, under conditions of reduced stringency, to the 14.6 kilobase pair (kbp) SVV BamHI B restriction endonuclease (RE) fragment  Fig. 1 ; genomic map coordinates 0"43 to 0.56). In order to map more precisely the SVV DNA sequence homologous to the VZV gB gene, the SVV BamHI B RE fragment was subcloned. Digestion of the SVV BamHI B RE fragment with HindIII RE generated five RE fragments which were subsequently cloned in pBC plasmid vectors. The organization of the HindIII subclones of the SVV BamHI B RE fragment (Fig. 1 c) was determined by RE analysis and Southern hybridization (data not shown).
Deoxyoligonucleotide primers, 5' ACCACCTCATC-GGTGGAATT 3' and 5' GTCGCCAATTTCTTCTA-TTG 3', spanning VZV nucleotides 58340 to 58359 and 59383 to 59364, respectively, were used to amplify by PCR approximately 1 kbp of the VZV gB DNA sequence (nucleotides 57008 to 59611 ; Davison & Scott, 1986) . The VZV gB PCR product was 32P-labelled using a random primers DNA labelling system (Bethesda Research Laboratories). The 32P-labelled VZV gB PCR product hybridized to the HindIII D subclone (map units 0"46 to 0.48) of the SVV BamHI B RE fragment indicating the presence of SVV DNA sequences homologous to the VZV gB gene (data not shown). The DNA sequence of the adjacent ends of the HindIII E (map units 0.45 to 0-46) and HindIII A (map units 0.48 to 0.52) subclones was determined by dideoxy-chain termination (Sanger et al., 1977) using Sequenase version 2.0 (USB). A search of the GenBank database indicated that the DNA sequence of the SVV HindIII E subclone, but not the HindIII A subclone, was homologous to the VZV gB gene. These data demonstrate that a SVV homologue of the VZV gB gene fine maps within the HindIII D and E subclones of the SVV BamHI B RE fragment corresponding to map units 0.45 to 0.48.
Unidirectional deletions of the HindIII D and E subclones of the SVV BamHI B RE fragment were generated using the Erase-A-Base system (Promega). The DNA sequence of the HindIII E and D subclones and the proximal end of the HindIII C subclone of the SVV BamHI B RE fragment was determined. DNA sequence data were assembled and analysed using the Genetics Computer Group (GCG) Sequence Analysis Software Package 7.2. DNA sequence analysis indicated a single 2751 base ORF. The SVV gB DNA sequence shares 71.1% identity with the Davison & Scott (1986) VZV gB DNA sequence, 53.8 % identity with the herpes simplex virus type 1 (HSV-1) gB DNA sequence, and 59-6 % identity with the equine herpesvirus type 1 (EHV-1) gB DNA sequence. The nucleotides found at the -3 (A) and + 4 (T) positions relative to the ATG initiation codon are not in agreement with Kozak's rule for translational initiation of eukaryotic mRNAs (Kozak, 1986) . Although a consensus polyadenylation signal (AATAAA) is not associated with the SVV gB ORF, three related sequences (TATAAT or ATAATA) are found immediately 3' to the SVV gB coding region.
The SVV gB ORF contains the genetic potential to encode a 916 amino acid protein with a predicted molecular mass of 104K. A potential signal sequence spanning amino acids 1 to 65 is found at the amino terminus of the predicted SVV gB polypeptide (McGeoch et al., 1985) . A hydrophobic region, encompassing amino acids 733 to 797, (hydrophobicity plot not shown) depicts three putative transmembrane regions (Kyte & Doolittle, 1982) . The Davison & Scott (1986) predicted VZV gB protein shares 78'9 % amino acid identity with the predicted SVV polypeptide sequence. Fig. 2 illustrates the alignment of the deduced polypeptide sequences of SVV, VZV, HSV-1 and EHV-1 gB homologues. These data show identical SVV gB and VZV gB predicted amino acid residues dispersed throughout the proteins. The predicted SVV and VZV gB proteins share seven conserved N-linked glycosylation sites (N-X-S/T) and a potential polypeptide cleavage site (amino acid sequence RRS; Keller et al., 1986; Whalley et al., 1989) . In addition, potential transmembrane regions of the SVV and VZV gB predicted polypeptides align precisely. The herpesvirus gB analogues presented share nine conserved cysteine residues and four regions, of unknown function, which are common among ! 3 analysed herpesvirus gB analogues (Borchers et al., 1991) .
Northern analysis was performed to demonstrate transcription of the SVV gB ORF. SVV infected cell and Vero cell total and polyadenylated RNA was isolated, denatured, and fractionated by electrophoresis through formaldehyde gels as described previously (Gray et al., 1987) . A a2P-labelled SVV gB (gplI) DNA fragment probe hybridized a 3-5 kilobase (kb) polyadenylated SVV transcript (Fig. 3 , lane 1). Single-stranded, antisense RNA probes generated from the HindIII E and HindIII D subclones using a riboprobe RNA labelling system (Promega) also hybridized to a 3"5 kb SVV mRNA (Fig. 3 , lanes 2 and 4). No mRNA was hybridized by sense RNA probes produced from the HindIII E and HindIII D subclones indicating that the complementary strand is not transcribed (Fig. 3 , lanes 3 and 5). These data demonstrate that the SVV gB is transcribed from left to right in the prototype SVV genomic orientation ( Fig.  1 e) .
The mRNA start sites of the SVV and VZV gB genes were determined by primer extension analysis using the AMV Reverse Transcriptase Primer Extension System (Promega). Extension of a SVV deoxyoligonucleotide primer (5' GTCCGGAACAAGCCGCTGAA 3', nucleotides + 124 to + 105 relative to the putative ATG initiation codon) generated two products 360 and 274 nucleotides in size (Fig. 4a) . The proximal 5' terminus relative to the predicted SVV gB protein start site is staggered between positions -147 to -150 (TGCC; Fig. 5 , nucleotides 253 to 256) whereas the distal SVV mRNA start site is an A residue positioned at -236 (nucleotide 167). A TATA motif is centred 22 base pairs (bp) upstream relative to the proximal SVV mRNA start site (nucleotides 224 to 238). The only consensus TATA motif found near the distal SVV mRNA start site is centred 65 bp upstream (nucleotides 96 to 110). Both SVV gB mRNA start sites predict the same ATG initiation codon.
Extension of a VZV gB deoxyoligonucleotide primer (5' GGCTCTACTTGTAAACTCTC 3', nucleotides 57072 to 57053) produced a 397 bp fragment (Fig. 4b) . The VZV mRNA start site is an A residue (nucleotide 56676) positioned within the VZV gene 30 coding sequences (nucleotides 54651 to 56960; Davison & Scott, 1986) . A TATA motif is found centred 30 bp 5' relative to the VZV mRNA start site (Fig. 5 , nucleotides 56638 to 56653). DNA sequence analysis indicates no conserved CAAT motifs for any start site found for either gB gene.
This study identifies and characterizes a SVV homologue of the VZV gB and HSV-1 gB genes. Based on analogy with HSV-1 gB, the SVV gB consists of three major domains: a hydrophobic extracellular domain of 732 amino acids, a 65 amino acid hydrophobic transmembrane domain and a charged intracellular carboxyterminal domain of 119 amino acids (Bzik et al., 1984) .
Characteristic of most transmembrane glycoproteins, the deduced SVV gB contains putative N-linked glycosylation sites, transmembrane regions and an aminoterminal signal sequence. The derived SVV gB polypeptide contains seven potential N-linked glycosylation sites conserved in the predicted VZV gB amino acid sequence (Fig. 2) . Several herpesvirus gB analogues, including VZV gB, have three predicted transmembrane segments (Davison & Scott, 1986; Bzik et al., 1984; Hammerschmidt et al., 1988; Albrecht & Fleckenstein, 1990) . The deduced SVV gB polypeptide also contains three potential transmembrane regions aligning closely with the predicted VZV [ Fig. 2 ; (Davison & Scott, 1986) ] and HSV-1 transmembrane regions (Bzik et al., 1984) . The third and most hydrophobic HSV-1 gB transmembrane region is sufficient for anchoring the glycoprotein (Rasile et al., 1993) . The third VZV and SVV gB transmembrane regions are also the most hydrophobic suggesting a similarity to the analogous HSV-1 gB transmembrane region. The predicted amino-terminal signal sequences of herpesvirus gB homologues vary considerably. The HSV-1 gB signal sequence is a predicted 30 amino acids in length (Bzik et al., 1984) whereas the EHV-1 predicted signal sequence is 86 amino acids in length (Whalley et al., 1989) . Hydrophobicity analysis (data not shown) of the SVV gB polypeptide sequence demonstrates an amino-terminal region indicative of a signal sequence 65 amino acids in size.
The HSV-1 gB is a homodimer composed of noncleaved polypeptides (Sarmiento & Spear, 1979) . However, the mature VZV gB is a disulphide-linked heterodimer generated by proteolytic cleavage of the nascent polypeptide. Amino-terminal sequence analysis indicates that cleavage between amino acids 493 to 495 generates the segments which comprise the VZV gB heterodimer (Keller et al., 1986) . This cleavage site (RRS) is conserved in the putative SVV gB polypeptide sequence, amino acids 487 to 489, suggesting a similar processing event for the SVV gB (Fig. 2) . In addition, the SVV, VZV, HSV-1 and EHV-1 predicted gB polypeptides contain nine conserved cysteine residues (Fig. 2) , suggesting a conservation of structure among herpesvirus gB homologues. The 3.5 kb SVV gB transcript corresponds in size to a RNA species previously mapped to a region of the SVV genome which includes the SVV gB gene . Two potential SVV gB transcript start sites were identified by 5' end mapping (Figs. 4 and 5 
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Consensus --- Fig. 2 . Alignment of the predicted SVV gB polypeptide sequence with other herpesvirus gB homologues. The SVV gB, VZV gB, HSV-1 gB and EHV-I gB predicted polypeptide sequences were aligned by the method of Feng & Doolittle (1987) . Vertical lines indicate identical amino acids conserved between the SVV gB and VZV gB deduced polypeptide sequences. Arrows display putative signal sequence cleavage sites for the SVV and VZV gB predicted proteins. The diamond indicates the VZV gB polypeptide start predicted by Davison & Scott (1986) . Asterisks indicate cysteine residues conserved among the herpesvirus gB analogues presented. SVV and VZV gB predicted N-linked glycosylation sites are indicated by double dashed lines. The four regions conserved among 13 herpesvirus gB homologues are illustrated by triple dashed lines (Borchers et al., 1991) . The SVV and VZV gB cleavage sites (RRS) and putative transmembrane regions are bracketed. The consensus line indicates amino acids conserved between the four herpesvirus gB analogues.
mRNA start sites predict the same initiation codon, the proximal site (nucleotides 253 to 256) is the most attractive candidate for a mRNA start site. A TATA motif centred 22 bp 5' to this mRNA start site contains a core region (ATATATT) which is conserved among other herpesvirus gB homologues including VZV, HSV-1 and PRV gBs (Bzik et al., 1984; Robbins et al., 1987) . In addition, this SVV mRNA start site and TATA box align closely with the VZV gB mRNA start site and TATA motif (Fig. 5) . The TATA motif centred 65 bp 5' to the distal mRNA start site may not be a true signal since TATA boxes generally occur 24 to 32 nucleotides 5' to mRNA initiation sites (Gannon et al., 1979 ; Busslinger et al., 1980) . VZV gB transcript analysis demonstrated a mRNA start site 30 bp 3' to a TATA motif containing the conserved core region ATATATT. However, this mRNA start site does not align with the previously reported VZV gB polypeptide start site (nucleotide 57008; Davison & Scott, 1986) . A potential ATG polypeptide initiation codon is found in frame and close to the mRNA start site (nucleotide 56819). Comparison of the SVV and VZV gB promoters demonstrates that the VZV translational start site found at nucleotide 56819 aligns precisely to the SVV gB ATG initiation codon (Fig. 5) . The signal sequence reported for the VZV gB is a mere eight amino acids in length (Keller et al., 1986) whereas the predicted SVV gB signal sequence is 65 amino acids in length. If the ATG codon beginning at nucleotide 56819 is the true start site of the protein, the VZV gB would be extended by 63 amino acids thus producing a signal sequence 71 amino acids in length. Interestingly, Massaer et al. (1993) observed no expression from a vaccinia virus construct containing the VZV gB encoding the eight amino acid signal sequence. However, with the extension of the construct to contain additional 5' sequences, the VZV gB was expressed. Therefore, the VZV gB polypeptide sequences may initiate at nucleotide 56819, generating a larger polypeptide than was originally predicted. The HSV-1 gB is essential for virus growth and mediates penetration of the virus particles Cai et al., 1988) . The HSV-1 gB is also an important target for the immune response which elicits T lymphocytes and humoral immunity (Cantin et al., 1987; Sanchez-Pescador et al., 1992) . Based on the nucleotide and amino acid identity shared between the gB homologues, the VZV and SVV gB polypeptides are likely to possess functions analogous to those of the HSV-1 gB. Like the HSV-1 gB, the VZV gB is highly antigenic and elicits humoral and cellular immunity. VZV gB generates the highest and most persistent antibody response in immunocompetent VZV infected patients (Larkin et al., 1985) . In addition, VZV gB elicits pronounced T and B cell responses during acute VZV infection and convalescence (Giller et al., 1989) .
VZV glycoproteins have been proposed as candidates for a varicella subunit vaccine (Vafai, 1993) . The simian varicella model offers an opportunity to evaluate the ability of viral glycoproteins to stimulate protective cellular and humoral immune responses. The ability of SVV gB immunization to protect monkeys against simian varicella and to prevent the establishment of SVV latent infection would indicate potential value of VZV gB as a component of a subunit vaccine. 
